Dr. Barry Dworkin

Aspirin use improves colon cancer survival for those who have a specific mutation called PIK3CA

Madely Health Headlines Commentary for October 25, 2012

Source:

Aspirin has selective benefit in colorectal cancer

Reference:

X. Liao et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. New England Journal of Medicine, Volume 367, Oct. 25, 2012, p. 1596. doi: 1056/NEJMoa1207756

Related posts:

  1. No conclusion about aspirin's effect on cancer risk reduction from observational study
  2. ASA study for cancer prevention interesting but leaves out large studies stating the opposite and uses studies not originally designed for cancer outcomes
  3. Sunday House Call, #406, July 22, 2012: A Big Whoop We Shouldn't Celebrate
  4. Meta-analysis cannot recommend ASA for primary prevention of heart disease and cancer in otherwise health people 50 years and up for lack of conclusive evvidence